Investors who lost more than $100,000 in ChampionX Corporation shares have until July 14, 2026 to become lead plaintiffs in a securities fraud class action lawsuit. The lawsuit alleges that ChampionX and its senior officers knowingly withheld material nonpublic information about Schlumberger Limited’s acquisition offers while the company repurchased its own shares at substantially lower prices, causing shareholder losses. If you held ChampionX stock during the class period of February 29, 2024 through April 1, 2024 and suffered significant losses, you may qualify to represent the class or join as a member investor. The claims center on what prosecutors describe as a coordinated deception: ChampionX allegedly conducted share buybacks at market prices while secretly aware that Schlumberger had offered substantially higher acquisition prices.
The acquisition was publicly announced on April 2, 2024 pre-market, eventually closing at $40.58 per share on July 16, 2025. Investors who sold shares during the hidden negotiation period claim they received unfairly depressed prices because management concealed information that would have affected their decisions. This case involves violations of the Securities Exchange Act of 1934 and represents the type of insider trading allegation that can yield significant settlements when evidence of nondisclosure is strong. Institutional investors and individuals with six-figure losses are being actively recruited to lead the litigation, which means bearing additional responsibility but also potentially influencing settlement strategy and receiving higher recoveries.
Table of Contents
- What Did ChampionX Allegedly Conceal About the Schlumberger Merger?
- How the Acquisition Timeline Reveals the Alleged Fraud Pattern
- What Constitutes “Material Nonpublic Information” in the ChampionX Case?
- How Much Loss Qualifies You as a Lead Plaintiff Candidate?
- What Are the Risks and Limitations for Lead Plaintiffs?
- What Documents and Evidence Will You Need?
- Securities Class Actions Typically Take Years to Resolve
What Did ChampionX Allegedly Conceal About the Schlumberger Merger?
ChampionX’s management allegedly engaged in share repurchases while in possession of confidential information about Schlumberger’s acquisition overtures. According to the lawsuit, Schlumberger made an initial offer below the eventual acquisition price, then raised that offer to $37.80 per share on March 7, 2024. During this same period—before any public disclosure—ChampionX was reportedly repurchasing shares “at market prices significantly below the prices offered by Schlumberger,” according to court documents. The defendants knew this information was not available to regular shareholders making their own trading decisions. The timing is critical to the allegation.
When ChampionX announced the Schlumberger merger on April 2, 2024, the deal price was significantly higher than what investors had been paying in the open market. Shareholders who sold during the February 29 to April 1 window claim they sold at artificially suppressed prices because management concealed the merger negotiations. This is analogous to situations like the 2020 case involving certain health insurance companies that failed to disclose pending regulatory decisions—where nondisclosure distorted stock prices and harmed shareholders selling at suppressed levels. The allegation focuses on what regulators call “selective disclosure” or outright concealment. Insiders who possess material nonpublic information cannot trade or allow their company to trade without disclosure, and they cannot simply keep the information quiet while watching the stock price move based on incomplete facts.
How the Acquisition Timeline Reveals the Alleged Fraud Pattern
The sequence of events suggests deliberate concealment. Between February 29 and April 1, 2024, Schlumberger was actively negotiating with ChampionX’s board. On March 7, 2024 specifically, Schlumberger raised its offer to $37.80 per share—a price that should have signaled to investors (had they known) that the company had substantial intrinsic value. Yet during this same window, ChampionX shares were trading lower in public markets, and the company was repurchasing shares at those lower prices.
Why would management buy back shares below an acquisition price it knew was pending? The answer prosecutors allege: ChampionX was illegally enriching itself through buybacks at suppressed prices while keeping shareholders in the dark. When the merger closed on July 16, 2025 at $40.58 per share, the benefit of that jump went to whoever still held shares—not to investors who had sold during the hidden negotiation period at much lower market prices. Investors who sold between February 29 and April 1, 2024 thus locked in losses compared to what they would have received if they had waited for the public disclosure. A significant limitation to understand: Even if the lawsuit succeeds, recovered damages typically reflect only the difference between what investors paid or sold at versus a fair price based on the withheld information. Investors don’t recover the full acquisition price; they recover losses attributable to nondisclosure.
What Constitutes “Material Nonpublic Information” in the ChampionX Case?
Material nonpublic information is any fact that a reasonable investor would consider important in making a buy or sell decision, and that is not yet available to the general public. In the ChampionX case, the material nonpublic information includes the existence of Schlumberger’s offer at $37.80 per share and the ongoing merger negotiations. The fact that Schlumberger was willing to pay that price is objectively material—it demonstrates enterprise value that the open market was not yet pricing in. The “nonpublic” element is equally important. ChampionX’s board and senior officers knew about the Schlumberger offer, but shareholders trading in the open market did not.
Under securities law, those with material nonpublic information cannot trade on it (insider trading) or allow their company to trade on it without disclosure. The company’s failure to disclose while repurchasing shares at lower market prices is the crux of the fraud allegation. Comparable cases include instances where executives know of pending product recalls or FDA rejections before they become public, creating an information asymmetry that harms shareholders. The law recognizes that markets depend on a level playing field. When insiders know something the market doesn’t, and they trade or allow the company to trade based on that knowledge, they’ve fundamentally violated the trust shareholders place in management.
How Much Loss Qualifies You as a Lead Plaintiff Candidate?
The notice specifically targets investors with losses in excess of $100,000. This threshold serves multiple purposes. It ensures that lead plaintiffs have a significant financial stake in the outcome, creating incentive to monitor the case closely. It also typically signals that the investor held a substantial position, which may mean they have detailed records and are more likely to actively participate in the litigation process. Lead plaintiffs often take depositions, review documents, and approve settlement agreements, so the role requires more than passive involvement.
If your losses exceed $100,000, you are being recruited specifically because your position size makes you a credible representative of the class. You would file a lead plaintiff application with the court, explaining your trading history and losses, and compete (sometimes) against other candidates. The court appoints the plaintiff deemed most adequate to represent the class. While lead plaintiffs can recover attorney’s fees awards and court-approved expenses, they also accept heightened scrutiny and are often targets in defendant motions challenging their adequacy. Non-lead plaintiffs with losses below $100,000 can still join the class and receive damages if the case settles or succeeds at trial, but they do not serve as representatives. The difference is meaningful: lead plaintiffs have more influence over strategy, while regular class members benefit from the litigation without that burden.
What Are the Risks and Limitations for Lead Plaintiffs?
Becoming a lead plaintiff carries significant risks that the recruitment materials may downplay. First, lead plaintiffs face extended discovery, meaning they may be deposed by defendant attorneys and asked detailed questions about their own trading decisions, investment knowledge, and records. This process can be uncomfortable and time-consuming. Second, defendants often file motions attacking the lead plaintiff’s adequacy, arguing that they don’t truly represent the class or have conflicts of interest. These motions can drag on for months and add stress to the process.
Third, and most importantly, there is no guarantee of recovery. Securities class actions depend on proving fraud, establishing damages, and often prevailing against well-funded defendant companies with experienced legal teams. Many cases settle for amounts substantially less than investors’ total losses. For example, a shareholder who lost $250,000 in a class action might recover $30,000 to $50,000 after attorney’s fees and costs. Lead plaintiffs are not indemnified against this risk; if the case fails, they may recover nothing and have invested significant time and emotional energy.
What Documents and Evidence Will You Need?
To qualify as a lead plaintiff or to file a claim, you will need documentation of your ChampionX transactions during the class period (February 29 to April 1, 2024) and any transactions before or after if relevant to calculating damages. This includes brokerage statements showing purchase dates, sale dates, and prices paid or received. If you purchased shares and held them through the acquisition, your statements should show the acquisition price received and the closing date (July 16, 2025).
If you sold shares during the class period, your statements show the price at which you sold and when. You will also want to document any losses claimed by calculating the difference between your purchase price and your selling price (if you sold during the class period) or between your purchase price and a fair value derived from the withheld information. The law firm representing the class will provide a detailed claims process, typically including a claims form that you submit along with photocopies of your brokerage statements. Keep detailed records; defendants often dispute both the timing of transactions and the damages calculated from them.
Securities Class Actions Typically Take Years to Resolve
A realistic timeline expectation is important. The ChampionX case was filed in 2026 with a lead plaintiff deadline of July 14, 2026. From that point, the litigation typically moves through several phases: lead plaintiff appointment, motion to dismiss, discovery (fact-gathering), expert disclosures, summary judgment motions, and either trial or settlement negotiations. Most securities class actions settle rather than go to trial, but settlement negotiations themselves can take years.
Comparable cases have taken four to seven years from filing to final distribution of settlement proceeds to class members. Once settlement is reached and approved by the court, there is often an additional 6-12 months for claims processing before checks are mailed to eligible investors. Patience is required. During this entire period, you should disregard day-to-day news about the case unless it involves actual trial dates or settlement announcements. Many investors in class actions become frustrated with the pace and abandon their claims or fail to file timely, missing recovery opportunities.